Annals of Laboratory Medicine

Korean Society for Laboratory Medicine (대한진단검사의학회)
권호 표지
DOI QR코드

DOI QR Code

Genetic Basis of Multidrug-resistant Acinetobacter baumannii Clinical Isolates from Three University Hospitals in Chungcheong Province, Korea

  • Koo, Sun-Hoe (Department of Laboratory Medicine, College of Medicine, Chungnam National University) ;
  • Kwon, Kye-Chul (Department of Laboratory Medicine, College of Medicine, Chungnam National University) ;
  • Cho, Hye-Hyun (Department of Laboratory Medicine, College of Medicine, Chungnam National University) ;
  • Sung, Ji-Youn (Department of Biomedical Laboratory Science, Far East University)
  • Received : 2010.07.15
  • Accepted : 2010.08.13
  • Published : 2010.10.01
⟨ Previous Next ⟩

Abstract

Background: The emergence of multidrug-resistant (MDR) Acinetobacter baumannii as an important opportunistic pathogen has given rise to significant therapeutic challenges in the treatment of nosocomial infections. In the present study, we assess the antibiotic resistance mechanisms of MDR A. baumannii strains by estimating the prevalence of antibiotic resistance determinants, including integrons, ${\beta}$-lactamases, str genes, and gyrA and parC mutations. Methods: Thirty-five MDR A. baumannii clinical isolates were collected from 3 Korean university hospitals over a 2-yr period. A. baumannii was confirmed by rpoB gene analysis. For each isolate, the minimal inhibitory concentrations (MICs) of 9 antibiotics were determined by the agar dilution method. PCR and DNA sequencing were used to identify the genes that potentially contribute to each resistance phenotype. Results: Of the 35 MDR A. baumannii isolates examined, 7 antibiotic resistance gene determinants were detected. These resistance gene determinants included the gene $bla_{OXA-23}$, with an upstream element ISAba1 to promote increased gene expression and subsequent resistance to carbapenems, in 8 isolates (22.9%); aacA4, located within class 1 integrons, in 7 isolates (20.0%); and fluoroquinolone resistance conferred by gyrA and parC sense mutations in 31 isolates. Conclusions: Of the 35 MDR A. baumannii isolates, 26 (74.3%) from both outbreak and sporadic cases possessed at least 4 of the 7 antibiotic resistance gene determinants that give rise to the MDR phenotype. The co-occurrence of several resistance determinants may present a significant threat.

Keywords

Acknowledgement

Supported by : Chungnam National University

References

  1. Bergogne-Berezin E and Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 1996;9:148-65.
  2. Petersen A, Guardabassi L, Dalsgaard A, Olsen JE. Class I integrons containing a dhfrI trimethoprim resistance gene cassette in aquatic Acinetobacter spp. FEMS Microbiol Lett 2000;182:73-6. https://doi.org/10.1111/j.1574-6968.2000.tb08876.x
  3. Recchia GD and Hall RM. Gene cassettes: a new class of mobile element. Microbiology 1995;141:3015-27. https://doi.org/10.1099/13500872-141-12-3015
  4. Srinivasan VB, Rajamohan G, Pancholi P, Stevenson K, Tadesse D, Patchanee P, et al. Genetic relatedness and molecular characterization of multidrug resistant Acinetobacter baumannii isolated in central Ohio, USA. Ann Clin Microbiol Antimicrob 2009;8:21. https://doi.org/10.1186/1476-0711-8-21
  5. Sung JY, Kwon KC, Park JW, Kim YS, Kim JM, Shin KS, et al. Dissemination of IMP-1 and OXA type b-lactamase in carbapenemresistant Acinetobacter baumannii. Korean J Lab Med 2008;28:16-23. https://doi.org/10.3343/kjlm.2008.28.1.16
  6. Nemec A, Dolzani L, Brisse S, van den Broek P, Dijkshoorn L. Diversity of aminoglycoside-resistance genes and their association with class 1 integrons among strains of pan-European Acinetobacter baumannii clones. J Med Microbiol 2004;53:1233-40. https://doi.org/10.1099/jmm.0.45716-0
  7. Poirel L, Pitout JD, Nordmann P. Carbapenemases: molecular diversity and clinical consequences. Future Microbiol 2007;2:501-12. https://doi.org/10.2217/17460913.2.5.501
  8. Afzal-Shah M, Woodford N, Livermore DM. Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother 2001;45:583-8. https://doi.org/10.1128/AAC.45.2.583-588.2001
  9. Naas T, Levy M, Hirschauer C, Marchandin H, Nordmann P. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-23 in a tertiary care hospital of Papeete, French Polynesia. J Clin Microbiol 2005;43:4826-9. https://doi.org/10.1128/JCM.43.9.4826-4829.2005
  10. Mugnier PD, Poirel L, Nordmann P. Functional analysis of insertion sequence ISAba1, responsible for genomic plasticity of Acinetobacter baumannii. J Bacteriol 2009;191:2414-8. https://doi.org/10.1128/JB.01258-08
  11. Vila J, Ruiz J, Goni P, Marcos A, Jimenez de Anta T. Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother 1995;39:1201-3. https://doi.org/10.1128/AAC.39.5.1201
  12. Lee MA and Moon HW. In vitro activity of antimicrobial combination against multidrug-resistant strains of Acinetobacter baumannii.Korean J Lab Med 2005;25:312-6.
  13. Ko KS, Suh JY, Kwon KT, Jung SI, Park KH, Kang CI, et al. High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea. J Antimicrob Chemother 2007;60:1163-7. https://doi.org/10.1093/jac/dkm305
  14. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 17th informational supplement. M100-S17. Wayne, PA: Clinical and Laboratory Standards Institute, 2007.
  15. Mak JK, Kim MJ, Pham J, Tapsall J, White PA. Antibiotic resistance determinants in nosocomial strains of multidrug-resistant Acinetobacter baumannii. J Antimicrob Chemother 2009;63:47-54. https://doi.org/10.1093/jac/dkn454
  16. Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 2006;27:351-3. https://doi.org/10.1016/j.ijantimicag.2006.01.004
  17. Vila J, Ruiz J, Goni P, Marcos A, Jimenez de Anta T. Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother 1995;39:1201-3. https://doi.org/10.1128/AAC.39.5.1201
  18. Valentine SC, Contreras D, Tan S, Real LJ, Chu S, Xu HH. Phenotypic and molecular characterization of Acinetobacter baumannii clinical isolates from nosocomial outbreaks in Los Angeles County, California. J Clin Microbiol 2008;46:2499-507. https://doi.org/10.1128/JCM.00367-08
  19. Shin SY, Kwon KC, Park JW, Song JH, Ko YH, Sung JY, et al. Characteristics of aac(6′)-Ib-cr gene in extended-spectrum $\beta$-lactamaseproducing Escherichia coli and Klebsiella pneumoniae isolated from Chungnam area. Korean J Lab Med 2009;29:541-50. https://doi.org/10.3343/kjlm.2009.29.6.541
  20. Bou G, Cervero G, Domínguez MA, Quereda C, Martinez-Beltran J. PCR-based DNA fingerprinting (REP-PCR, AP-PCR) and pulsedfield gel electrophoresis characterization of a nosocomial outbreak caused by imipenem- and meropenem-resistant Acinetobacter baumannii. Clin Microbiol Infect 2000;6:635-43. https://doi.org/10.1046/j.1469-0691.2000.00181.x
  21. Turton JF, Ward ME, Woodford N, Kaufmann ME, Pike R, Livermore DM, et al. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett 2006; 258:72-7. https://doi.org/10.1111/j.1574-6968.2006.00195.x
  22. Gallego L and Towner KJ. Carriage of class 1 integrons and antibiotic resistance in clinical isolates of Acinetobacter baumannii from northern Spain. J Med Microbiol 2001;50:71-7. https://doi.org/10.1099/0022-1317-50-1-71
  23. Gombac F, Riccio ML, Rossolini GM, Lagatolla C, Tonin E, Monti- Bragadin C, et al. Molecular characterization of integrons in epidemiologically unrelated clinical isolates of Acinetobacter baumannii from Italian hospitals reveals a limited diversity of gene cassette arrays. Antimicrob Agents Chemother 2002;46:3665-8. https://doi.org/10.1128/AAC.46.11.3665-3668.2002
  24. Turton JF, Kaufmann ME, Glover J, Coelho JM, Warner M, Pike R, et al. Detection and typing of integrons in epidemic strains of Acinetobacter baumannii found in the United Kingdom. J Clin Microbiol 2005;43:3074-82. https://doi.org/10.1128/JCM.43.7.3074-3082.2005
  25. Heritier C, Poirel L, Nordmann P. Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii. Clin Microbiol Infect 2006;12:123-30. https://doi.org/10.1111/j.1469-0691.2005.01320.x
  26. Corvec S, Caroff N, Espaze E, Giraudeau C, Drugeon H, Reynaud A. AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strains. J Antimicrob Chemother 2003;52:629-35. https://doi.org/10.1093/jac/dkg407
  27. Akasaka T, Tanaka M, Yamaguchi A, Sato K. Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance. Antimicrob Agents Chemother 2001;45:2263-8. https://doi.org/10.1128/AAC.45.8.2263-2268.2001
  28. Lee JK, Lee YS, Park YK, Kim BS. Mutations in the gyrA and parC genes in ciprofloxacin-resistant clinical isolates of Acinetobacter baumannii in Korea. Microbiol Immunol 2005;49:647-53. https://doi.org/10.1111/j.1348-0421.2005.tb03643.x

Cited by

  1. Antimicrobial Resistance Determinants in Imipenem-nonsusceptible Acinetobacter calcoaceticus-baumannii Complex Isolated in Daejeon, Korea vol.31, pp.4, 2010, https://doi.org/10.3343/kjlm.2011.31.4.265
  2. Multidrug-Resistant Acinetobacter spp.: Increasingly Problematic Nosocomial Pathogens vol.52, pp.6, 2010, https://doi.org/10.3349/ymj.2011.52.6.879
  3. The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace vol.3, pp.None, 2010, https://doi.org/10.3389/fmicb.2012.00148
  4. Antibiotic resistance and carriage class 1 and 2 integrons in clinical isolates of Acinetobacter baumannii from Tehran, Iran vol.3, pp.2, 2010, https://doi.org/10.1016/s2221-1691(13)60038-6
  5. Adding risk factors for potentially resistant pathogens, increasing antibiotic pressure and risk creating the “untreatable bacteria”: time to change direction vol.39, pp.4, 2010, https://doi.org/10.1007/s00134-012-2811-x
  6. Nosocomial Infection by Sequence Type 357 Multidrug-Resistant Acinetobacter baumannii Isolates in a Neonatal Intensive Care Unit in Daejeon, Korea vol.33, pp.4, 2013, https://doi.org/10.3343/alm.2013.33.4.279
  7. Detection of class 1 integron in Acinetobacter baumannii isolates collected from nine hospitals in Turkey vol.3, pp.9, 2010, https://doi.org/10.1016/s2221-1691(13)60149-5
  8. Molecular Characteristics ofblaOXA-23-ProducingAcinetobacter baumanniiIsolated from a University Hospital vol.16, pp.3, 2010, https://doi.org/10.5145/acm.2013.16.3.126
  9. Infections Caused by Acinetobacter baumannii in Recipients of Hematopoietic Stem Cell Transplantation vol.4, pp.None, 2010, https://doi.org/10.3389/fonc.2014.00186
  10. Molecular Identification and Antimicrobial Resistance Profile of Acinetobacter baumannii Isolated From Nosocomial Infections of a Teaching Hospital in Isfahan, Iran vol.1, pp.3, 2010, https://doi.org/10.17795/ajcmi-21489
  11. Emergence of Acinetobacter pittii Harboring New Delhi Metallo-β-Lactamase Genes in Daejeon, Korea vol.35, pp.5, 2010, https://doi.org/10.3343/alm.2015.35.5.531
  12. Persistence of Multidrug-Resistant Acinetobacter baumannii Isolates Harboring blaOXA-23 and bap for 5 Years vol.26, pp.8, 2010, https://doi.org/10.4014/jmb.1604.04049
  13. 다제내성 Acinetobacter baumannii 의 항생제 내성 유전자 분석 vol.48, pp.3, 2010, https://doi.org/10.15324/kjcls.2016.48.3.217
  14. A multi-center study on the risk factors of infection caused by multi-drug resistant Acinetobacter baumannii vol.18, pp.None, 2018, https://doi.org/10.1186/s12879-017-2932-5
  15. Prevalence of extended-spectrum beta-lactamase genes in Acinetobacter baumannii strains isolated from nosocomial infections in Tehran, Iran vol.14, pp.None, 2010, https://doi.org/10.3205/dgkh000318
  16. Molecular mechanisms associated with quinolone resistance in Enterobacteriaceae: review and update vol.114, pp.10, 2010, https://doi.org/10.1093/trstmh/traa041
  17. Characteristics of Quinolone Resistance in Multidrug-Resistant Acinetobacter baumannii Strains Isolated from General Hospitals vol.14, pp.3, 2010, https://doi.org/10.5812/jjm.115128